GT200100236A - Kit de repinotano. - Google Patents

Kit de repinotano.

Info

Publication number
GT200100236A
GT200100236A GT200100236A GT200100236A GT200100236A GT 200100236 A GT200100236 A GT 200100236A GT 200100236 A GT200100236 A GT 200100236A GT 200100236 A GT200100236 A GT 200100236A GT 200100236 A GT200100236 A GT 200100236A
Authority
GT
Guatemala
Prior art keywords
repinotane
kit
inofensive
physiologically
salt
Prior art date
Application number
GT200100236A
Other languages
English (en)
Inventor
Werner Kroll
Ferdinand Rombout
Horst Weber
Maria-Luisa Rodriguez
Bernd Sennhenn
Rudolf Schohe-Loop
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of GT200100236A publication Critical patent/GT200100236A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors

Abstract

LA INVENCION TRATA DE UN KIT QUE INCLUYE UNA COMPOSICION FARMACEUTICA, QUE CONTIENE REPINOTANO O UNA SAL FISIOLOGICAMENTE INOFENSIVA DE REPINOTANO, Y A UN MEDIO PARA DETERMINAR LA CONCENTRACION DE REPINOTANO O SUS METABOLITOS EN LIQUIDOS CORPORALES, ASI COMO NUEVAS COMPOSICIONES FARMACEUTICAS, QUE CONTIENEN REPINOTANO O UNA SAL FISIOLOGICAMENTE INOFENSIVA DE REPINOTANO, Y PROCEDIMIENTOS PARA LA PREPARACION DE ESTOS.
GT200100236A 2000-11-22 2001-11-22 Kit de repinotano. GT200100236A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10058119A DE10058119A1 (de) 2000-11-22 2000-11-22 Pepinotan-Kit

Publications (1)

Publication Number Publication Date
GT200100236A true GT200100236A (es) 2002-06-25

Family

ID=7664358

Family Applications (1)

Application Number Title Priority Date Filing Date
GT200100236A GT200100236A (es) 2000-11-22 2001-11-22 Kit de repinotano.

Country Status (37)

Country Link
US (2) US6605255B2 (es)
EP (1) EP1339403B1 (es)
JP (2) JP2004517824A (es)
KR (1) KR20030096237A (es)
CN (2) CN1715279A (es)
AR (1) AR031761A1 (es)
AT (1) ATE284212T1 (es)
AU (1) AU2002227912A1 (es)
BG (1) BG107803A (es)
BR (1) BR0115518A (es)
CA (1) CA2429310A1 (es)
CZ (1) CZ20031401A3 (es)
DE (2) DE10058119A1 (es)
DO (1) DOP2001000293A (es)
EC (1) ECSP034617A (es)
EE (1) EE200300242A (es)
ES (1) ES2234922T3 (es)
GT (1) GT200100236A (es)
HN (1) HN2001000262A (es)
HR (1) HRP20030490A2 (es)
HU (1) HUP0303294A2 (es)
IL (1) IL155975A0 (es)
MA (1) MA26059A1 (es)
MX (1) MXPA03004499A (es)
MY (1) MY118345A (es)
NO (1) NO20032212D0 (es)
NZ (1) NZ525964A (es)
PE (1) PE20020533A1 (es)
PL (1) PL361628A1 (es)
PT (1) PT1339403E (es)
RU (1) RU2003118583A (es)
SI (1) SI1339403T1 (es)
SK (1) SK5922003A3 (es)
SV (1) SV2003000744A (es)
UY (1) UY27027A1 (es)
WO (1) WO2002041881A2 (es)
ZA (1) ZA200303888B (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6861422B2 (en) * 2003-02-26 2005-03-01 Boehringer Ingelheim Pharma Gmbh & Co. Kg Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions
DE102004010050A1 (de) * 2004-03-02 2005-09-22 Bayer Healthcare Ag Spezifische monoklonale und polyklonale Antikörper für Repinotan und dessen ringoffene Form
DE102004029784A1 (de) * 2004-06-21 2006-01-05 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue 2-Benzylaminodihydropteridinone, Verfahren zur deren Herstellung und deren Verwendung als Arzneimittel
DE102004033670A1 (de) * 2004-07-09 2006-02-02 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Pyridodihydropyrazinone, Verfahren zu Ihrer Herstellung und Ihre Verwendung als Arzneimittel
US20060058311A1 (en) 2004-08-14 2006-03-16 Boehringer Ingelheim International Gmbh Combinations for the treatment of diseases involving cell proliferation
US20060074088A1 (en) * 2004-08-14 2006-04-06 Boehringer Ingelheim International Gmbh Dihydropteridinones for the treatment of cancer diseases
US7728134B2 (en) * 2004-08-14 2010-06-01 Boehringer Ingelheim International Gmbh Hydrates and polymorphs of 4[[(7R)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pteridinyl]amino]-3-methoxy-N-(1-methyl-4-piperidinyl)-benzamide, process for their manufacture and their use as medicament
US7759485B2 (en) * 2004-08-14 2010-07-20 Boehringer Ingelheim International Gmbh Process for the manufacture of dihydropteridinones
US20060035903A1 (en) * 2004-08-14 2006-02-16 Boehringer Ingelheim International Gmbh Storage stable perfusion solution for dihydropteridinones
EP1630163A1 (de) * 2004-08-25 2006-03-01 Boehringer Ingelheim Pharma GmbH & Co.KG Dihydropteridinonderivative, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
EP1632493A1 (de) * 2004-08-25 2006-03-08 Boehringer Ingelheim Pharma GmbH & Co.KG Dihydropteridinonderivative, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
DE102004058337A1 (de) * 2004-12-02 2006-06-14 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung von annelierten Piperazin-2-on Derivaten
US7439358B2 (en) * 2006-02-08 2008-10-21 Boehringer Ingelheim International Gmbh Specific salt, anhydrous and crystalline form of a dihydropteridione derivative
EP3098223A1 (en) * 2007-08-03 2016-11-30 Boehringer Ingelheim International GmbH Crystalline form of a dihydropteridione derivative
US8546566B2 (en) 2010-10-12 2013-10-01 Boehringer Ingelheim International Gmbh Process for manufacturing dihydropteridinones and intermediates thereof
US9358233B2 (en) 2010-11-29 2016-06-07 Boehringer Ingelheim International Gmbh Method for treating acute myeloid leukemia
US9370535B2 (en) 2011-05-17 2016-06-21 Boehringer Ingelheim International Gmbh Method for treatment of advanced solid tumors
US20150031699A1 (en) 2013-07-26 2015-01-29 Boehringer Ingelheim International Gmbh Treatment of myelodysplastic syndrome
US9867831B2 (en) 2014-10-01 2018-01-16 Boehringer Ingelheim International Gmbh Combination treatment of acute myeloid leukemia and myelodysplastic syndrome

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3901814A1 (de) 1988-07-28 1990-02-01 Bayer Ag Substituierte aminomethylzetraline sowie ihre heterocyclischen analoga
DE19522088A1 (de) * 1995-06-19 1997-01-02 Bayer Ag Benzisothiazolyl-substituierte Aminomethylchromane
DE19543476A1 (de) * 1995-11-22 1997-05-28 Troponwerke Gmbh & Co Kg Verwendung von substituierten Aminomethyl-chromanen zur Behandlung von Schädel-Hirn-Trauma
DE19751949A1 (de) * 1997-11-24 1999-05-27 Bayer Ag Verwendung von substituierten Aminomethyl-Chromanen zur Verhinderung der neuronalen Degeneration und zur Förderung der neuronalen Regeneration
DE19754573A1 (de) * 1997-12-09 1999-06-10 Bayer Ag Pharmazeutische Zusammensetzung zur Behandlung von Schlaganfall und Schädel-Hirn-Trauma
US6663833B1 (en) * 1998-03-10 2003-12-16 Strategic Diagnostics Inc. Integrated assay device and methods of production and use
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
DE19936281C2 (de) 1999-08-02 2002-04-04 Bayer Ag Verfahren zur Gefriertrocknung

Also Published As

Publication number Publication date
NO20032212L (no) 2003-05-15
PL361628A1 (en) 2004-10-04
NO20032212D0 (no) 2003-05-15
UY27027A1 (es) 2002-07-31
KR20030096237A (ko) 2003-12-24
CN1715279A (zh) 2006-01-04
SV2003000744A (es) 2003-01-13
ATE284212T1 (de) 2004-12-15
PT1339403E (pt) 2005-03-31
BG107803A (bg) 2004-01-30
BR0115518A (pt) 2003-09-16
MA26059A1 (fr) 2004-04-01
HN2001000262A (es) 2002-01-30
PE20020533A1 (es) 2002-07-13
SI1339403T1 (en) 2005-04-30
MY118345A (en) 2004-10-30
JP2004517824A (ja) 2004-06-17
SK5922003A3 (en) 2003-11-04
HRP20030490A2 (hr) 2005-06-30
HUP0303294A2 (en) 2007-09-28
ZA200303888B (en) 2004-05-20
NZ525964A (en) 2006-02-24
MXPA03004499A (es) 2004-05-14
AR031761A1 (es) 2003-10-01
ES2234922T3 (es) 2005-07-01
WO2002041881A2 (de) 2002-05-30
EE200300242A (et) 2003-10-15
US20030060493A1 (en) 2003-03-27
RU2003118583A (ru) 2004-12-20
US6605255B2 (en) 2003-08-12
CZ20031401A3 (cs) 2003-10-15
WO2002041881A3 (de) 2002-10-10
DOP2001000293A (es) 2002-03-15
AU2002227912A1 (en) 2002-06-03
CN1518446A (zh) 2004-08-04
JP2005232189A (ja) 2005-09-02
ECSP034617A (es) 2003-06-25
IL155975A0 (en) 2003-12-23
CA2429310A1 (en) 2002-05-30
DE50104790D1 (de) 2005-01-13
EP1339403A2 (de) 2003-09-03
US20030203953A1 (en) 2003-10-30
EP1339403B1 (de) 2004-12-08
DE10058119A1 (de) 2002-05-23

Similar Documents

Publication Publication Date Title
GT200100236A (es) Kit de repinotano.
HN2002000154A (es) Azaindoles
UY28348A1 (es) Compuestos novedosos
SV2002000776A (es) Nuevas imidazotriazinonas sustituidas ref.lea 34 985-sv
CR7583A (es) Nueva sal formiato de o-desmetil venlafaxina
HN2006019066A (es) "(s)-n-metilnaltrexona"
SV2006002174A (es) Composicion de anticuerpo her2
PA8684501A1 (es) Formulaciones de estrogenos conjugados y bazedoxifeno
UY27175A1 (es) Nueva sal succinato de o-desmetil- venlafaxina
DE60106954D1 (de) Resorcin-derivate
HN2006019068A (es) "sintesis de (r)-n-metilnaltrexona"
CR8257A (es) Construcciones de union y metodos para uso de ellas
CR8428A (es) Agente endoparasiticidas para la administracion topica
HN2002000300A (es) Nuevos derivados de piperazina
SE9901077D0 (sv) Novel use
ECSP034531A (es) Derivados sustituidos de c-ciclohexilmetilamina
HN2001000235A (es) Derivados puentes de piperazina
DE50205129D1 (de) 8-tetradecenal als duft- oder aromastoff
RS51534B (en) NEW COMPOUND OF SINUSOID IF CURRENT INHIBITORS AND CALCIUM INHIBITOR AND PHARMACEUTICAL MIXTURE CONTAINED BY IT
ES2189072T3 (es) Nuevo benzo-cicloalquenos heterociclicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
BR0009194A (pt) Composição do resorcinol
HN2001000021A (es) Nuevos derivados de amidas heterociclicas
CR7672A (es) Metodo microbiologico para la produccion de 11- alfa- hidroxiesteroides 7- alfa sustituidos
DE60136064D1 (de) Wässrige flüssige preparation von pranoprofen
SV2002000639A (es) Alcanosulfonatos de fenoxifenilo ref. lea 34813-sv